Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) is a clinical research site located in New Brunswick, New Jersey, United States 08901.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers.
Sponsors: BioNTech SE.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers.
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.